Prostate Testing for Cancer and Treatment (ProtecT) feasibility study by J. Donovan, F. Hamdy, D. Neal, T. Peters, S. Oliver, L. Brindle, D. Jewell, P. Powell, D. Gillatt, D. Dedman, N. Mills, M. Smith, S. Noble, A. Lane, ProtecT Study Group

Get full text

Modelling the lifetime cost-effectiveness of radical prostatectomy, radiotherapy and active monitoring for men with clinically localised prostate cancer from median 10-year outcome... by S. Sanghera, S. Mohiuddin, J. Coast, K. Garfield, S. Noble, C. Metcalfe, J. A. Lane, E. L. Turner, D. Neal, F. C. Hamdy, R. M. Martin, J. L. Donovan, for the ProtecT study group

Get full text

Factors associated with trial recruitment, preferences, and treatments received were elucidated in a comprehensive cohort study. by Donovan, JL, Opmeer, B, Young, GJ, Mills, N, Martin, RM, Lane, JA, Metcalfe, C, Peters, TJ, Davis, M, Turner, EL, Walsh, E, Neal, DE, Hamdy, FC, ProtecT Study Group

A prospective cohort and extended comprehensive-cohort design provided insights about the generalizability of a pragmatic trial: the ProtecT prostate cancer trial by Donovan, JL, Young, GJ, Walsh, EI, Metcalfe, C, Lane, JA, Martin, RM, Tazewell, MK, Davis, M, Peters, TJ, Turner, EL, Mills, N, Khazragui, H, Khera, TK, Neal, DE, Hamdy, FC, ProtecT Study Group

Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of participatory and informed consent (PIC) by Wade, J, Elliott, D, Avery, K, Gaunt, D, Young, G, Barnes, R, Paramasivan, S, Campbell, W, Blazeby, J, Birtle, A, Stein, R, Beard, D, Halliday, A, Donovan, J, ProtecT study group, CLASS study group, Chemorad study group, POUT study group, OPTIMA prelim study group, CSAW study group, ACST-2 study group

Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of Participatory and Informed Consent (PIC) by Julia Wade, Daisy Elliott, Kerry N. L. Avery, Daisy Gaunt, Grace J. Young, Rebecca Barnes, Sangeetha Paramasivan, W Bruce Campbell, Jane M. Blazeby, Alison J Birtle, Rob C. Stein, David J Beard, Alison W Halliday, Jenny L. Donovan, On behalf of the ProtecT study group, CLASS study group, Chemorad study group, POUT study group, OPTIMA prelim study group, CSAW study group and ACST-2 study group

Get full text

Mortality among nen with advanced prostate cancer excluded from the ProtecT Trial by Johnston, T, Shaw, G, Lamb, A, Parashar, D, Greenberg, D, Xiong, T, Edwards, A, Gnanapragasam, V, Holding, P, Herbert, P, Davis, M, Mizielinsk, E, Lane, J, Oxley, J, Robinson, M, Mason, M, Staffurth, J, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Kockelbergh, R, Kynaston, H, Prescott, S, Paul, A, Powell, P, Rosario, D, Rowe, E, Donovan, J, Hamdy, F, Neal, D, ProtecT study group

Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer by Donovan, J, Hamdy, F, Lane, J, Mason, M, Metcalfe, C, Walsh, E, Blazeby, J, Peters, T, Holding, P, Bonnington, S, Lennon, T, Bradshaw, L, Cooper, D, Herbert, P, Howson, J, Jones, A, Lyons, N, Salter, E, Thompson, P, Tidball, S, Blaikie, J, Gray, C, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Kockelbergh, R, Kynaston, H, Paul, A, Powell, P, Prescott, S, Rosario, D, Rowe, E, Davis, M, Turner, E, Martin, R, Neal, D, ProtecT Study Group

Active monitoring, radical prostatectomy and radical radiotherapy in PSA-detected clinically localised prostate cancer: The ProtecT three-arm RCT by Hamdy, FC, Donovan, JL, Lane, JA, Mason, M, Metcalfe, C, Peter Holding, Wade, J, Noble, S, Garfield, K, Young, G, Davis, M, Peters, TJ, Turner, EL, Martin, RM, Oxley, J, Robinson, M, Staffurth, J, Walsh, E, Blazeby, J, Bryant, R, Bollina, P, Catto, J, Doble, A, Doherty, A, Gillatt, D, Gnanapragasam, V, Hughes, O, Kockelbergh, R, Kynaston, H, Paul, A, Paez, E, Powell, P, Prescott, S, Rosario, D, Rowe, E, Neal, D

Other Authors: “…ProtecT Study Group…”